To investigate whether LPP promotes breast tumour cell intravasation in vivo, we injected NMuMG-ErbB2 and NIC breast cancer cells that possessed LucA- and LPP-shRNAs, into the mammary fat pads of immunocompromised mice. This evidence concerns the gene ERBB2 and breast carcinoma.